Salesforce Stock Is at a 3-Year Low. Should Investors Consider Buying?

Salesforce is down more than 40% in 2026 and recently closed slightly above $153, a three-year low, but the article argues fundamentals remain solid: last quarter revenue and earnings beat expectations and free cash flow reached $6.6 billion. Investor concerns center on AI monetization risk from Agentforce cannibalizing seat-based subscriptions and the $3.6 billion acquisition of Fin, which adds about 30,000 customers but may signal growth via M&A rather than organically.

Analysis

The market is treating CRM like a secular loser, but the more interesting setup is that this is becoming a capital-allocation and narrative-failure trade rather than a clean fundamentals short. If AI agents improve enterprise workflow efficiency, the first-order concern is seat compression; the second-order effect is that the platform becomes more embedded and harder to displace, which can actually raise switching costs even as ARPU per user comes under pressure. That makes the near-term multiple compression understandable, but not necessarily durable if management can convert usage growth into consumption-based monetization over the next 2-4 quarters.

The Fin acquisition signals a different problem: CRM is buying distribution and adjacency because organic expansion is slowing. That can be value-accretive if integration improves attach rates into an installed base of tens of thousands of customers, but it also risks turning the company into a roll-up story where growth quality deteriorates and investors apply a lower terminal multiple. The key second-order read-through is to smaller service workflow and customer-support software vendors: Fin’s customer overlap suggests CRM may be pre-empting a broader consolidation wave in service AI, which could pressure standalone names with weaker scale or less data.

The contrarian setup is that sentiment appears more damaged than cash generation. The market is pricing in a binary AI cannibalization outcome, but the base case over the next 6-12 months is likely a slower, messier transition where CRM offsets seat erosion with higher module penetration, services attach, and price discipline. If management shows even modest evidence that AI drives net expansion rather than substitution, the stock can re-rate quickly because expectations are already depressed; if not, the downside is probably a grind rather than a cliff unless margins start to compress.

Key Decisions for Investors

• Long CRM on weakness for a 3-6 month tactical rebound; risk/reward improves if shares stay near multi-year lows while free cash flow remains intact, with a stop if upcoming quarters show margin compression or net retention deterioration.
• Buy CRM call spreads 6-9 months out to express a moderated rebound view; the setup favors limited premium outlay because sentiment is depressed, but upside likely depends on incremental AI monetization proof rather than a full rerating.
• Pair trade: long CRM / short a higher-multiple SaaS name with weaker cash generation and similar AI-cannibalization exposure over the next 1-2 quarters; this isolates valuation normalization from sector beta.
• Short standalone customer-service workflow vendors with limited scale if CRM’s Fin integration looks successful; the thesis is that CRM can bundle AI-powered service into existing enterprise contracts, pressuring smaller point solutions over 6-12 months.
• If CRM rallies hard on headline optimism, trim into strength rather than chase; the stock likely needs two clean quarters of evidence before the market will pay for the AI story again.